PIQ

2.17%

67.5¢

PROTEOMICS INTERNATIONAL LABORATORIES LTD

Market Cap $88.42M Add to my watchlist

Healthcare Biotechnology

Proteomics International Laboratories Ltd is an Australia-based medical technology... Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bioanalytical services. It specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. It focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identified up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.More

Latest Threads

Tag

Subject

PIQ

Ann: December 2024 Quarterly Activities Report and Appendix 4C

23/01/25

3.2K

23/01/25

Last post BellGuide3124

3.2K

PIQ

Ann: Novel OxiDx test detects muscle damage in elite athletes

19/01/25

7.7K

19/01/25

Last post dsa69

7.7K

PIQ

PIQ Chart

14/01/25

4.4K

14/01/25

Last post FindMyBroker

4.4K

PIQ

Should Shareholders Help PIQ & other the companies they invest in?

06/01/25

1.2K

06/01/25

Last post BellGuide3124

1.2K

PIQ

Endo Test in The Australian Today

04/01/25

6.0K

04/01/25

Last post daicosisgod

6.0K

PIQ

Ann: Breakthrough results for endometriosis diagnostic blood test

31/12/24

6.5K

31/12/24

Last post Dilmac

6.5K

PIQ

Endo Test on 7 news Tonight

30/12/24

1.0K

30/12/24

Last post Strewth!

1.0K

PIQ

Ann: Investor Presentation

30/12/24

4.7K

30/12/24

Last post crisendy

4.7K

See All Discussions

Timeline

December 2024 Quarterly Activities Report and Appendix 4C
21 Jan 08:16	Share

Novel OxiDx test detects muscle damage in elite athletes
31 Dec 08:20	Share

Breakthrough results for endometriosis diagnostic blood test
30 Dec 08:22	Share

Notification regarding unquoted securities - PIQ
17 Dec 12:24	Share

Issue of Equity Incentives to Employees
17 Dec 12:10	Share

Proteomics receives $2.16 million in R&D tax incentive
16 Dec 08:27	Share

Change of Directors' Interest Notices
21 Nov 13:22	Share

Notification regarding unquoted securities - PIQ
21 Nov 13:13	Share

Notification regarding unquoted securities - PIQ
21 Nov 12:45	Share

Investor Presentation
20 Nov 08:17	Share

Initial Director's Interest Notice
14 Nov 14:31	Share

Final Director's Interest Notice
14 Nov 14:31	Share

Amended Constitution
08 Nov 15:21	Share

Results of Meeting
08 Nov 15:17	Share

AGM Chairman's Address and Investor Presentation
08 Nov 11:55	Share

Board renewal update
30 Oct 08:20	Share

September 2024 Quarterly Activities Report and Appendix 4C
22 Oct 08:09	Share

Notification of cessation of securities - PIQ
14 Oct 11:54	Share

PromarkerD predicts kidney decline in T1D - study published
11 Oct 08:23	Share

Notice of Annual General Meeting/Proxy Form
09 Oct 12:55	Share

Esophageal cancer diagnostic delivers excellent results
23 Sep 08:29	Share

Initial Director's Interest Notice
20 Sep 10:55	Share

Investor Presentation
19 Sep 08:25	Share

Appointment of Director
16 Sep 08:20	Share

Update on commercialisation of PromarkerD in the USA
11 Sep 08:16	Share

Notification of cessation of securities - PIQ
27 Aug 10:30	Share

Groundbreaking results for type 1 diabetes and kidney health
23 Aug 09:01	Share

Annual Report to shareholders
23 Aug 08:06	Share

Corporate Governance Statement and Appendix 4G
23 Aug 08:06	Share

Preliminary Final Report
23 Aug 08:06	Share

View More

(20min delay)
Last 67.5¢		Change -0.015(2.17%)		Mkt cap ! $88.42M

Open	High	Low	Value	Volume
68.5¢	69.0¢	66.0¢	$146.2K	216.4K

Buyers (Bids)

No.	Vol.	Price($)
1	22323	67.5¢

Sellers (Offers)

Price($)	Vol.	No.
70.0¢	35000	1

View Market Depth

No.	Vol.	Price($)
1	22323	0.675
5	39022	0.650
3	10885	0.640
1	2700	0.635
2	15580	0.630

Price($)	Vol.	No.
0.700	35000	1
0.710	30704	2
0.720	5000	1
0.725	10000	1
0.740	22050	2

Last trade - 16.10pm 23/01/2025 (20 minute delay)

PIQ (ASX) Chart

PROTEOMICS INTERNATIONAL LABORATORIES LTD

Latest Threads

Timeline

Featured News

Latest Videos

Proteomics International Laboratories (ASX:PIQ) receives reimbursement approval for PromarkerD

03 Jan 2023 08:23 (AEDT)

Latest Articles

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

Proteomics International Laboratories Ltd has ended its licencing agreement with Sonic Healthcare USA in relation to PromarkerD.

Proteomics appoints Growth Medics to drive European sales

Proteomics International Laboratories has engaged Growth Medics B.V., to assist with the selection of EU alliance partners for its PromarkerD predictive test for diabetic kidney disease.

Proteomics International subsidiary secures European patent for OxiDx technology

Proteomics International Laboratories (ASX: PIQ) has announced that its subsidiary, OxiDx, has secured a patent across 19 major European countries for its platform technology designed to assess oxidative stress.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News